ArticleJournal of materials science. Materials in medicine2026
Enhancing bone repair ability of 3D-printed PLLA scaffolds via N-methyl-2-pyrrolidone etching.
Article in Journal of materials science. Materials in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of bone repair scaffolds has long been a research hotspot in tissue engineering. Owing to its unique capability for personalized customization of scaffold geometry and microstructure, 3D printing technology has been extensively adopted for fabricating bone repair scaffolds. Poly-L-lactic acid (PLLA), endowed with favorable biodegradability, excellent biocompatibility, and reliable in vivo safety, is widely used as a matrix material for 3D printed bone repair scaffolds. PLLA is a bioinert polymer characterized by inferior cell adhesion and osteogenic differentiation capabilities. To mitigate this bioinertness limitation, the present study employed N-methylpyrrolidone (NMP) etching to modify the surface of 3D-printed PLLA bone repair scaffolds. Following NMP etching for 1-24 h, the originally smooth scaffold surface evolved into a hierarchical, petal-like gradient microstructure, accompanied by a marked increase in surface roughness. Correspondingly, the hydrophilicity of the treated scaffolds was also enhanced. Differential scanning calorimetry (DSC) and X-ray diffraction (XRD) analyses further confirmed that the crystallinity of PLLA in the scaffolds was significantly enhanced. Concomitantly, the modified scaffolds exhibited a marked improvement in adsorption capacity for green fluorescent protein (GFP), while the adhesion and proliferation of MC3T3-E1 on their surface were also significantly promoted. In vivo animal experiments demonstrated that the NMP-etched scaffolds could accelerate the process of bone defect repair. Collectively, surface modification of 3D-printed PLLA bone scaffolds via NMP etching enables precise modulation of their physicochemical properties, thereby effectively mitigating the inherent bioinertness limitation of PLLA scaffolds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.